International Journal of Molecular Sciences Publishes Preclinical Data of Panavance’s Misetionamide (GP-2250) in Melanoma
Misetionamide is effective in targeting and killing BRAF-mutated melanoma cells while preserving normal cells
BRAF-mutated..
GlobeNewswire